Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006972
Filing Date
2023-04-27
Accepted
2023-04-27 08:40:36
Documents
7
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230608xdef14a.htm DEF 14A 765057
2 GRAPHIC tmb-20230608xdef14a_a001.jpg GRAPHIC 7106
3 GRAPHIC tmb-20230608xdef14a_a002.jpg GRAPHIC 3530
4 GRAPHIC tmb-20230608xdef14a_a003.jpg GRAPHIC 5683
5 GRAPHIC tmb-20230608xdef14a_a004.jpg GRAPHIC 7180
6 GRAPHIC tmb-20230608xdef14a_bg001.jpg GRAPHIC 112533
7 GRAPHIC tmb-20230608xdef14a_bg002.jpg GRAPHIC 124500
  Complete submission text file 0001558370-23-006972.txt   1125877
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38520 | Film No.: 23852136
SIC: 2836 Biological Products, (No Diagnostic Substances)